The global Contract Research Organization (CRO) market size was valued at US$ 75150 million in 2024 and is forecast to a readjusted size of USD 156100 million by 2031 with a CAGR of 11.1% during review period.
A Contract Research Organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of outsourced research services. These services can range across various stages of the drug development process, including preclinical research, clinical trials, regulatory affairs, data management, and market analysis. CROs offer their expertise to help these industries develop and commercialize new drugs, therapies, and medical devices, often by managing or conducting the clinical trials that are required by regulatory agencies before a product can enter the market.
Global Contract Research Organization (CRO) key players include Labcorp, IQVIA, ICON, Parexel, Syneos Health, etc. Global top five manufacturers hold a share over 30%. USA is the largest market, with a share over 45%, followed by Europe and China, both have a share over 40%. In terms of product, Clinical Trial CRO is the largest segment, with a share over 65%. And in terms of application, the largest application is Pharmaceutical, followed by Biotechnology, Medical Device, etc.
The Contract Research Organization (CRO) market has been growing and evolving rapidly, influenced by changes in the pharmaceutical, biotech, and medical device industries. Here are the key trends shaping the CRO market:
Increased Outsourcing in Biopharma and Medical Device Sectors
Growing Demand for R&D Outsourcing: Pharmaceutical and biotech companies are increasingly outsourcing clinical trials and drug development tasks to CROs to reduce costs, speed up timelines, and gain access to specialized expertise.
Small and Mid-Sized Enterprises (SMEs): Smaller companies with limited resources, especially in the biotech sector, are using CRO services to manage their clinical and preclinical studies, focusing on their core research areas.
Adoption of Decentralized and Hybrid Clinical Trials
Decentralized Clinical Trials (DCTs): The COVID-19 pandemic accelerated the adoption of remote and decentralized trials, where CROs use technology like wearable devices, telemedicine, and remote monitoring to reduce patient site visits.
Hybrid Trials: Many CROs are now supporting hybrid trial models, where some trial elements are conducted on-site and others remotely, allowing greater flexibility in patient recruitment and retention.
Increased Focus on Rare Diseases and Specialty Therapies
Orphan Drugs and Personalized Medicine: CROs are focusing more on rare disease trials and personalized medicine, which require niche expertise and innovative trial designs. This focus is driven by advances in genetic and biomarker testing, which allow for more targeted treatment approaches.
Oncology: As one of the most active areas of clinical research, oncology continues to drive demand for CROs due to the complexity and duration of cancer trials and the need for innovative approaches in recruitment and data analysis.
Technological Advancements in Data Collection and Analysis
Artificial Intelligence (AI) and Machine Learning (ML): CROs are leveraging AI and ML for predictive analytics, patient recruitment, and data analysis, enhancing efficiency and accuracy in clinical trials.
Digital Health Tools and Wearable Technology: Real-time data collection from wearables and other digital health devices allows CROs to monitor patient health remotely and continuously, reducing reliance on site visits and improving data quality.
This report is a detailed and comprehensive analysis for global Contract Research Organization (CRO) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Contract Research Organization (CRO) market size and forecasts, in consumption value ($ Million), 2020-2031
Global Contract Research Organization (CRO) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Contract Research Organization (CRO) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Contract Research Organization (CRO) market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Contract Research Organization (CRO)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Contract Research Organization (CRO) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Labcorp, IQVIA, Syneos Health, Parexel, PRA, PPD, CRL, ICON, Wuxi Apptec, Medpace Holdings, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Contract Research Organization (CRO) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Preclinical CRO
Clinical Trial CRO
麻豆原创 segment by Application
Pharmaceutical
Biotechnology
Medical Device
Others
麻豆原创 segment by players, this report covers
Labcorp
IQVIA
Syneos Health
Parexel
PRA
PPD
CRL
ICON
Wuxi Apptec
Medpace Holdings
Tigermed
Boji Medical Technology
Pharmaron
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Contract Research Organization (CRO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Contract Research Organization (CRO), with revenue, gross margin, and global market share of Contract Research Organization (CRO) from 2020 to 2025.
Chapter 3, the Contract Research Organization (CRO) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Contract Research Organization (CRO) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Contract Research Organization (CRO).
Chapter 13, to describe Contract Research Organization (CRO) research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Contract Research Organization (CRO) by Type
1.3.1 Overview: Global Contract Research Organization (CRO) 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Contract Research Organization (CRO) Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Preclinical CRO
1.3.4 Clinical Trial CRO
1.4 Global Contract Research Organization (CRO) 麻豆原创 by Application
1.4.1 Overview: Global Contract Research Organization (CRO) 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical
1.4.3 Biotechnology
1.4.4 Medical Device
1.4.5 Others
1.5 Global Contract Research Organization (CRO) 麻豆原创 Size & Forecast
1.6 Global Contract Research Organization (CRO) 麻豆原创 Size and Forecast by Region
1.6.1 Global Contract Research Organization (CRO) 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Contract Research Organization (CRO) 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Contract Research Organization (CRO) 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Contract Research Organization (CRO) 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Contract Research Organization (CRO) 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Contract Research Organization (CRO) 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Contract Research Organization (CRO) 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Labcorp
2.1.1 Labcorp Details
2.1.2 Labcorp Major Business
2.1.3 Labcorp Contract Research Organization (CRO) Product and Solutions
2.1.4 Labcorp Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Labcorp Recent Developments and Future Plans
2.2 IQVIA
2.2.1 IQVIA Details
2.2.2 IQVIA Major Business
2.2.3 IQVIA Contract Research Organization (CRO) Product and Solutions
2.2.4 IQVIA Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 IQVIA Recent Developments and Future Plans
2.3 Syneos Health
2.3.1 Syneos Health Details
2.3.2 Syneos Health Major Business
2.3.3 Syneos Health Contract Research Organization (CRO) Product and Solutions
2.3.4 Syneos Health Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Syneos Health Recent Developments and Future Plans
2.4 Parexel
2.4.1 Parexel Details
2.4.2 Parexel Major Business
2.4.3 Parexel Contract Research Organization (CRO) Product and Solutions
2.4.4 Parexel Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Parexel Recent Developments and Future Plans
2.5 PRA
2.5.1 PRA Details
2.5.2 PRA Major Business
2.5.3 PRA Contract Research Organization (CRO) Product and Solutions
2.5.4 PRA Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 PRA Recent Developments and Future Plans
2.6 PPD
2.6.1 PPD Details
2.6.2 PPD Major Business
2.6.3 PPD Contract Research Organization (CRO) Product and Solutions
2.6.4 PPD Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 PPD Recent Developments and Future Plans
2.7 CRL
2.7.1 CRL Details
2.7.2 CRL Major Business
2.7.3 CRL Contract Research Organization (CRO) Product and Solutions
2.7.4 CRL Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 CRL Recent Developments and Future Plans
2.8 ICON
2.8.1 ICON Details
2.8.2 ICON Major Business
2.8.3 ICON Contract Research Organization (CRO) Product and Solutions
2.8.4 ICON Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 ICON Recent Developments and Future Plans
2.9 Wuxi Apptec
2.9.1 Wuxi Apptec Details
2.9.2 Wuxi Apptec Major Business
2.9.3 Wuxi Apptec Contract Research Organization (CRO) Product and Solutions
2.9.4 Wuxi Apptec Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Wuxi Apptec Recent Developments and Future Plans
2.10 Medpace Holdings
2.10.1 Medpace Holdings Details
2.10.2 Medpace Holdings Major Business
2.10.3 Medpace Holdings Contract Research Organization (CRO) Product and Solutions
2.10.4 Medpace Holdings Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Medpace Holdings Recent Developments and Future Plans
2.11 Tigermed
2.11.1 Tigermed Details
2.11.2 Tigermed Major Business
2.11.3 Tigermed Contract Research Organization (CRO) Product and Solutions
2.11.4 Tigermed Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Tigermed Recent Developments and Future Plans
2.12 Boji Medical Technology
2.12.1 Boji Medical Technology Details
2.12.2 Boji Medical Technology Major Business
2.12.3 Boji Medical Technology Contract Research Organization (CRO) Product and Solutions
2.12.4 Boji Medical Technology Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Boji Medical Technology Recent Developments and Future Plans
2.13 Pharmaron
2.13.1 Pharmaron Details
2.13.2 Pharmaron Major Business
2.13.3 Pharmaron Contract Research Organization (CRO) Product and Solutions
2.13.4 Pharmaron Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Pharmaron Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Contract Research Organization (CRO) Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Contract Research Organization (CRO) by Company Revenue
3.2.2 Top 3 Contract Research Organization (CRO) Players 麻豆原创 Share in 2024
3.2.3 Top 6 Contract Research Organization (CRO) Players 麻豆原创 Share in 2024
3.3 Contract Research Organization (CRO) 麻豆原创: Overall Company Footprint Analysis
3.3.1 Contract Research Organization (CRO) 麻豆原创: Region Footprint
3.3.2 Contract Research Organization (CRO) 麻豆原创: Company Product Type Footprint
3.3.3 Contract Research Organization (CRO) 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Contract Research Organization (CRO) Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Contract Research Organization (CRO) 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Contract Research Organization (CRO) Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Contract Research Organization (CRO) 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Contract Research Organization (CRO) Consumption Value by Type (2020-2031)
6.2 North America Contract Research Organization (CRO) 麻豆原创 Size by Application (2020-2031)
6.3 North America Contract Research Organization (CRO) 麻豆原创 Size by Country
6.3.1 North America Contract Research Organization (CRO) Consumption Value by Country (2020-2031)
6.3.2 United States Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Contract Research Organization (CRO) Consumption Value by Type (2020-2031)
7.2 Europe Contract Research Organization (CRO) Consumption Value by Application (2020-2031)
7.3 Europe Contract Research Organization (CRO) 麻豆原创 Size by Country
7.3.1 Europe Contract Research Organization (CRO) Consumption Value by Country (2020-2031)
7.3.2 Germany Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Contract Research Organization (CRO) Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Contract Research Organization (CRO) Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Contract Research Organization (CRO) 麻豆原创 Size by Region
8.3.1 Asia-Pacific Contract Research Organization (CRO) Consumption Value by Region (2020-2031)
8.3.2 China Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Contract Research Organization (CRO) Consumption Value by Type (2020-2031)
9.2 South America Contract Research Organization (CRO) Consumption Value by Application (2020-2031)
9.3 South America Contract Research Organization (CRO) 麻豆原创 Size by Country
9.3.1 South America Contract Research Organization (CRO) Consumption Value by Country (2020-2031)
9.3.2 Brazil Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Contract Research Organization (CRO) Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Contract Research Organization (CRO) Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Contract Research Organization (CRO) 麻豆原创 Size by Country
10.3.1 Middle East & Africa Contract Research Organization (CRO) Consumption Value by Country (2020-2031)
10.3.2 Turkey Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Contract Research Organization (CRO) 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Contract Research Organization (CRO) 麻豆原创 Drivers
11.2 Contract Research Organization (CRO) 麻豆原创 Restraints
11.3 Contract Research Organization (CRO) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Contract Research Organization (CRO) Industry Chain
12.2 Contract Research Organization (CRO) Upstream Analysis
12.3 Contract Research Organization (CRO) Midstream Analysis
12.4 Contract Research Organization (CRO) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Labcorp
IQVIA
Syneos Health
Parexel
PRA
PPD
CRL
ICON
Wuxi Apptec
Medpace Holdings
Tigermed
Boji Medical Technology
Pharmaron
听
听
*If Applicable.
